Muvalaplin, a novel oral medication, safely and effectively lowers high levels of lipoprotein(a), or Lp(a), results from the phase 2 KRAKEN trial show. Concentrations of Lp(a) cholesterol are ...

Zebra Technologies Trading Down 2.2 % NASDAQ ZBRA opened at $385.91 on Friday. The stock has a 50-day moving average of $370.36 and a 200-day moving average of $338.44. The company has a current ...